Last Updated on June 22, 2023

Metabolic Brain Disease- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Springer New York

Abbreviation: Metab. Brain Dis.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

3.53

SJR

 0.761

h-Index

 74

Rank

 6398

Important Details

Title Metabolic Brain Disease
Standard Abbreviation Metab. Brain Dis.
Type of Publication Journal
Discipline Biochemistry (Q2); Neurology (clinical) (Q2); Cellular and Molecular Neuroscience (Q3)
Impact Score 3.53
SCImago Journal Rank (SJR) 0.761
h-index 74
Overall Rank 6398
Publisher Name Springer New York
Publication Country United States
International Standard Serial Number (ISSN) 15737365, 08857490
Coverage and History 1986-2022
Best Quartile Q2
Total Citations Received
(Last 3 Year)
1908

About Metabolic Brain Disease


Metabolic Brain Disease is a journal published by Springer New York. This journal covers the area[s] related to Biochemistry, Neurology (clinical), Cellular and Molecular Neuroscience, etc. The coverage history of this journal is as follows: 1986-2022. The rank of this journal is 6398. This journal's impact score, h-index, and SJR are 3.53, 74, and 0.761, respectively. The ISSN of this journal is/are as follows: 15737365, 08857490.

The best quartile of Metabolic Brain Disease is Q2. This journal has received a total of 1908 citations during the last three years (Preceding 2022).


Metabolic Brain Disease Impact Score 2022-2023


The latest impact score (IS) of the Metabolic Brain Disease is 3.53. It is computed in the year 2023 as per its definition and based on Scopus data. 3.53

It is decreased by a factor of around 0.11, and the percentage change is -3.02% compared to the preceding year 2021, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Metabolic Brain Disease Impact Score 2023


Impact Score 2022 of Metabolic Brain Disease is 3.53. If a similar downward trend continues, IS may decrease in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Metabolic Brain Disease. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 3.53
2021 3.64
2020 3.19
2019 2.79
2018 2.46
2017 2.49
2016 2.35
2015 2.79
2014 3.00

Metabolic Brain Disease h-index


  Table Setting

The h-index of Metabolic Brain Disease is 74. By definition of the h-index, this journal has at least 74 published articles with more than 74 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Metabolic Brain Disease ISSN


The International Standard Serial Number (ISSN) of Metabolic Brain Disease is/are as follows: 15737365, 08857490.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Metabolic Brain Disease Ranking and SCImago Journal Rank (SJR)


The Metabolic Brain Disease is ranked 6398 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.761.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Metabolic Brain Disease Publisher


Table Setting

The publisher of Metabolic Brain Disease is Springer New York. The publishing house of this journal is located in the United States. Its coverage history is as follows: 1986-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Metabolic Brain Disease is Metab. Brain Dis.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Metab. Brain Dis.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Metabolic Brain Disease


If your area of research or discipline is related to Biochemistry, Neurology (clinical), Cellular and Molecular Neuroscience, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Metabolic Brain Disease?

The latest impact score of Metabolic Brain Disease is 3.53. It is computed in the year 2023.


What is the h-index of Metabolic Brain Disease?

The latest h-index of Metabolic Brain Disease is 74. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Metabolic Brain Disease?

The latest SCImago Journal Rank (SJR) of Metabolic Brain Disease is 0.761. It is calculated in the year 2023.


What is the ranking of Metabolic Brain Disease?

The latest ranking of Metabolic Brain Disease is 6398. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Metabolic Brain Disease?

Metabolic Brain Disease is published by Springer New York. The publication country of this journal is United States.


What is the abbreviation of Metabolic Brain Disease?

This standard abbreviation of Metabolic Brain Disease is Metab. Brain Dis..


Is "Metabolic Brain Disease" a Journal, Conference or Book Series?

Metabolic Brain Disease is a journal published by Springer New York.


What is the scope of Metabolic Brain Disease?

The scope of Metabolic Brain Disease is as follows:

  • Biochemistry
  • Neurology (clinical)
  • Cellular and Molecular Neuroscience

For detailed scope of Metabolic Brain Disease, check the official website of this journal.


What is the ISSN of Metabolic Brain Disease?

The International Standard Serial Number (ISSN) of Metabolic Brain Disease is/are as follows: 15737365, 08857490.


What is the best quartile for Metabolic Brain Disease?

The best quartile for Metabolic Brain Disease is Q2.


What is the coverage history of Metabolic Brain Disease?

The coverage history of Metabolic Brain Disease is as follows 1986-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Historia Journal Universidade Estadual Paulista 27560 7 0.02
Current Sociology Journal SAGE Publications Ltd 6591 76 2.29
International Journal of Parallel, Emergent and Distributed Systems Journal Taylor and Francis Ltd. 15843 23 1.28
European Journal of Education Journal Wiley-Blackwell Publishing Ltd 6079 53 2.31
Syntax Journal Wiley-Blackwell Publishing Ltd 3422 29 0.93
Studies in Continuing Education Journal Routledge 6011 38 2.81
Palaeontographica Abteilung B: Palaeophytologie Book Series E. Schweizerbart'sche Verlagsbuchhandlung 15138 16 2.20
Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute Journal Hoikkaido Forest Products Research Institute 25369 4 0.00
Archives of the Balkan Medical Union Journal Balkan medical union 23243 10 0.24
Journal of Immigrant and Refugee Studies Journal Routledge 9246 32 1.46

Check complete list




Metabolic Brain Disease Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 3.53
2021 3.64
2020 3.19
2019 2.79
2018 2.46
2017 2.49
2016 2.35
2015 2.79
2014 3.00



Top Journals/Conferences in Biochemistry

Cell
Cell Press | United States

Nature Medicine
Nature Publishing Group | United Kingdom

Nature Methods
Nature Publishing Group | United Kingdom

Nature Catalysis
Nature Publishing Group | United States

Annual Review of Biochemistry
Annual Reviews Inc. | United States

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

Nature Reviews Methods Primers
Springer Nature | United States

Annual Review of Biophysics
Annual Reviews Inc. | United States

Chem
Elsevier Inc. | United States

Nature Protocols
Nature Publishing Group | United Kingdom

Annals of the Rheumatic Diseases
BMJ Publishing Group | United Kingdom

Molecular Systems Biology
Wiley-Blackwell | United States

Journal of the American Chemical Society
American Chemical Society | United States

Cell Reports Medicine
Cell Press | United States

EMBO Journal
Wiley-Blackwell | Germany

See All

Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

Autism in Adulthood
Mary Ann Liebert Inc. | United States

Sleep Medicine Reviews
Elsevier BV | United Kingdom

Stroke
American Heart Association | United States

European Stroke Journal
SAGE Publications Inc. | United States

Annual Review of Vision Science
Annual Reviews Inc. | United States

See All

Top Journals/Conferences in Cellular and Molecular Neuroscience

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Molecular Psychiatry
Nature Publishing Group | United Kingdom

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Translational Neurodegeneration
BioMed Central Ltd. | United Kingdom

Journal of Neuroinflammation
BioMed Central Ltd. | United Kingdom

Acta neuropathologica communications
BioMed Central Ltd. | United Kingdom

GLIA
John Wiley & Sons Inc. | United States

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

Cell Death and Disease
Nature Publishing Group | United Kingdom

Translational Psychiatry
Nature Publishing Group | United Kingdom

npj Parkinson's Disease
Springer Nature | United States

PLoS Computational Biology
Public Library of Science | United States

Cerebral Cortex
Oxford University Press | United Kingdom

See All